Skip to content
OpenCapital
Get started

Veracyte VCYT Other Research And Development Expense

Other Research And Development Expense at other companies

Celanese Corporation logo
Celanese CorporationCE
$0—
Corvex logo
Corvex MOVE
$899K+12.4%
Disc Medicine logo
Disc MedicineIRON
$2.17M+18.2%
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.49M+25.5%
Ashland logo
AshlandASH
$1M—

Segments

By segment

See full
Reportable Segment$5.46M+201%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×